GlassScriptPhysician profile
Brian M Spittle
NPI 1407856040
$6,388.00
in general payments reported to CMS, 2019-2025
9 companies · $3,567 in 2025
The $3,567 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $653 · 2020: $194 · 2021: $32.58 · 2022: $20.92 · 2023: $895 · 2024: $1,026 · 2025: $3,567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,373 · Food and Beverage: $1,892 · Consulting Fee: $600 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Entertainment: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,373.07 |
| Food and Beverage | $1,891.57 |
| Consulting Fee | $600.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Entertainment | $123.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $4,819.38 | 2019-2025 | Biofinity Contact Lens, Misight Contact Lens, Myday Contact Lens |
| Alcon Vision LLC | $639.17 | 2019-2025 | Precision 1, Precision7 |
| Bausch & Lomb Americas INC. | $292.76 | 2022-2025 | Infuse |
| Maculogix, INC. | $171.89 | 2019-2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $157.86 | 2019-2020 | |
| Optos, INC. | $123.00 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Topcon Healthcare, INC. | $122.31 | 2025 | |
| Carl Zeiss Meditec, INC. | $42.88 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $18.75 | 2023 | Acuvue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Spittle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.